First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Mathijs P. Hendriks et al.|The Lancet Oncology|2023Cited by 168
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver MetastasesMarinde J. G. Bond, Leonie J. Mekenkamp, Karen Bolhuis et al.|JAMA Oncology|2024Cited by 26
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal CancerSietske C. van Nassau, Lieke H. J. Simkens, Marinde J. G. Bond et al.|JAMA Network Open|2021Cited by 10